These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3194130

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Calcitonin in hypercalcaemia.
    Bijvoet OL, van der Sluys Veer J, Jansen AP.
    Lancet; 1968 Jul 27; 2(7561):218. PubMed ID: 4173430
    [No Abstract] [Full Text] [Related]

  • 25. [Carbocalcitonin in the treatment of senile osteoporosis and hypercalcemic syndromes].
    Nardini F, Barbagli R, Rossi F.
    Clin Ter; 1988 Oct 15; 127(1):17-25. PubMed ID: 2976337
    [No Abstract] [Full Text] [Related]

  • 26. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
    Azzoini P.
    Clin Ter; 1981 Apr 30; 97(2):147-52. PubMed ID: 7237955
    [No Abstract] [Full Text] [Related]

  • 27. [Drug therapy in acute hypercalcemia].
    Frey H.
    Tidsskr Nor Laegeforen; 1974 May 10; 94(13):847-8. PubMed ID: 4832538
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of a hypercalcemic crisis in a myelomatous patient under chronic hemodialysis. The role of calcitonin].
    Bissoli F, Simonati V, Volpini T, Novi C.
    Minerva Nefrol; 1980 May 10; 27(2):351-4. PubMed ID: 7219856
    [No Abstract] [Full Text] [Related]

  • 29. Thyro calcitonin and age.
    Orimo H, Hirsch PF.
    Endocrinology; 1973 Nov 10; 93(5):1206-11. PubMed ID: 4778765
    [No Abstract] [Full Text] [Related]

  • 30. Nasal human calcitonin for tumor-induced hypercalcemia.
    Dumon JC, Magritte A, Body JJ.
    Calcif Tissue Int; 1992 Jul 10; 51(1):18-9. PubMed ID: 1393770
    [Abstract] [Full Text] [Related]

  • 31. [Therapeutic possibilities in paraneoplastic hypercalcemia].
    Schürer CC, Peters U, Fischer JT.
    Med Welt; 1981 Aug 14; 32(32-33):1219-21. PubMed ID: 6456397
    [No Abstract] [Full Text] [Related]

  • 32. [Therapy of hypercalcemia].
    Kuhlencordt F.
    Dtsch Med Wochenschr; 1967 Apr 04; 92(14):671-2. PubMed ID: 6024542
    [No Abstract] [Full Text] [Related]

  • 33. [Acute hypercalcemic crisis in primary hyperparathyroidism].
    Kistler HJ.
    Minerva Med; 1974 Dec 19; 65(91):4815-20. PubMed ID: 4449611
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of hypercalcemia with Asu 1,7 eel calcitonin].
    Kudo S, Nakamura I, Sakagami M, Fukuchi S.
    Horumon To Rinsho; 1979 Feb 19; 27(2):179-83. PubMed ID: 428129
    [No Abstract] [Full Text] [Related]

  • 35. [Thyrocalcitonin and its clinical use].
    Migunova NA, Nikiforova NV, Ermolenko VM, Briskin AI.
    Sov Med; 1973 Apr 19; 36(4):34-8. PubMed ID: 4588905
    [No Abstract] [Full Text] [Related]

  • 36. Human synthetic calcitonin therapy for hypercalcemia of immobilization.
    Kaul S, Sockalosky JJ.
    J Pediatr; 1995 May 19; 126(5 Pt 1):825-7. PubMed ID: 7752017
    [Abstract] [Full Text] [Related]

  • 37. [Effects of calcitonin treatment in hypercalcemia associated with malignant neoplasms].
    Miura S, Yoshida Y, Murai H.
    Horumon To Rinsho; 1975 Aug 19; 23(8):809-15. PubMed ID: 1238199
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM, Tuel SM, Cross LL.
    Arch Phys Med Rehabil; 1993 Mar 19; 74(3):316-9. PubMed ID: 8439262
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of hypercalcemia].
    Thorsen N, Ditzel J.
    Ugeskr Laeger; 1968 Oct 17; 130(42):1761-6. PubMed ID: 4972886
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.